LS
Louis W Sullivan (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in United Therapeutics Corporation (UTHR). The largest single filing was $3.0M of UTHR (5,950 sh across 2 lots, as filed), executed Dec 22 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.0M
shares × price, as filed
Last traded
Dec 22 2025
Filed Dec 23 2025
Median ADV $265.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $12.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
UTHRRecent filings
UTHRSALE
United Therapeutics Corporation
View filing →
$3.0M5,950 sh across 2 lots
Exec Dec 22 2025
Filed Dec 23 2025 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $9.5M
25,509 sh across 19 lots
Exec Dec 18 2024
Filed Dec 19 2024 · 5:30 PM ET